A Randomized, Double-blind, Placebo-controlled Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JX2105 in Healthy Chinese Subjects
Clinical trial NCT06537050 · UNKNOWN
Trial details
- NCT number
- NCT06537050
- Sponsor
- Zhejiang Jingxin Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2025-01-30
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.